Drugs that contain Eprosartan Mesylate; Hydrochlorothiazide
1. Teveten Hct patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5656650 | ABBVIE | Angiotensin II receptor blocking compositions |
Aug, 2014
(9 years ago) | |
Market Authorisation Date: 01 November, 2001
Treatment: Treatment of hypertension
Dosage: TABLET;ORAL
More Information on Dosage
TEVETEN HCT family patents
